XML 49 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 3 Months Ended
Mar. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule Of Changes In Carrying Amount Of Goodwill
Changes in the carrying amount of goodwill for the three months ended March 31, 2014 were as follows:
 
 
U.S.
Neurosurgery
 
U.S.
Instruments
 
U.S.
Extremities
 
U.S.
Spine
and
Other
 
International
 
Total
 
(In thousands)
Goodwill, gross
$
95,165

 
$
58,033

 
$
61,079

 
$
56,325

 
$
25,900

 
$
296,502

Accumulated impairment losses


 


 


 
(46,738
)
 


 
(46,738
)
Goodwill at December 31, 2013
95,165

 
58,033

 
61,079

 
9,587

 
25,900

 
249,764

Confluent Surgical acquisition - preliminary allocation
94,315

 
—

 
—

 
—

 
23,400

 
117,715

Foreign currency translation
88

 
27

 
28

 
4

 
23

 
170

Goodwill at March 31, 2014
$
189,568

 
$
58,060

 
$
61,107

 
$
9,591

 
$
49,323

 
$
367,649
Components Of Company's Identifiable Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 
 
March 31, 2014
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
18 years
 
$
320,460

 
$
(49,607
)
 
$
270,853

Customer relationships
12 years
 
146,701

 
(81,926
)
 
64,775

Trademarks/brand names
31 years
 
33,601

 
(15,726
)
 
17,875

Trademarks/brand names
Indefinite
 
48,484

 
—

 
48,484

Supplier relationships
27 years
 
34,721

 
(9,677
)
 
25,044

All other (1)
4 years
 
4,652

 
(2,237
)
 
2,415

 
 
 
$
588,619

 
$
(159,173
)
 
$
429,446


 
December 31, 2013
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
12 years
 
$
81,238

 
$
(45,343
)
 
$
35,895

Customer relationships
12 years
 
146,627

 
(79,624
)
 
67,003

Trademarks/brand names
31 years
 
33,703

 
(15,648
)
 
18,055

Trademarks/brand names
Indefinite
 
48,484

 
—

 
48,484

Supplier relationships
27 years
 
34,721

 
(9,305
)
 
25,416

All other (1)
5 years
 
4,251

 
(1,941
)
 
2,310

 
 
 
$
349,024

 
$
(151,861
)
 
$
197,163


 
(1) 
At March 31, 2014 and December 31, 2013, all other included in-process research and development ("IPR&D") of $1.4 million in both periods, which was indefinite-lived.